Finance

Lists
Why is FMCQF down 4,35%?
Dive Deeper
FMCQF:OTCMKTS
Fresenius Medical Care AG
42,37 US$
-4,35%
(-1,93) 1D
7 ოქტ, 16:00:00 GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for FMCQF...
Open
42,37 US$
High
42,37 US$
Low
42,37 US$
Mkt. cap
11,23 მლრდ.
Avg. vol.
158,00
Volume
100,00
52-wk high
56,24 US$
52-wk low
42,00 US$
Beta
0,81
Shares outstanding
268,56 მლნ.
No. of employees
107 ათ.
Open
42,37 US$
High
42,37 US$
Low
42,37 US$
Mkt. cap
11,23 მლრდ.
Avg. vol.
158,00
Volume
100,00
52-wk high
56,24 US$
52-wk low
42,00 US$
Beta
0,81
Shares outstanding
268,56 მლნ.
No. of employees
107 ათ.
News stories
From web sources and news partners
Profile
Fresenius Medical Care AG & Co. KGaA is a German healthcare company which provides kidney dialysis services through a network of 4,171 outpatient dialysis centers, serving 345,425 patients. The company primarily treats end-stage renal disease, which requires patients to undergo dialysis 3 times per week for the rest of their lives. With a global headquarters in Bad Homburg vor der Höhe, Germany, and a North American headquarters in Waltham, Massachusetts, it has a 38% market share of the dialysis market in the United States. It also operates 42 production sites, the largest of which are in the U.S., Germany, and Japan. The company is 32% owned by Fresenius and, as of 2020, generates around 50% of the group's revenue. As of 2024, the company was ranked as #612 on the World's Best Employers list published by Forbes. Wikipedia
About Fresenius Medical Care AG
CEOჰელენ გიზა
Employees107 ათ.
Founded1996
Headquarters-
SectorHealth care provider
Websitefreseniusmedicalcare.com
Previous reportsAll values in EUR
Loading Previous Earnings...
Revenue
Net income
All values in EUR
სექ. 2025
დეკ. 2025
მარ. 2026
ივნ. 2026
Revenue
4,88 მლრდ.
5,07 მლრდ.
4,61 მლრდ.
4,86 მლრდ.
Cost of goods sold
3,64 მლრდ.
3,68 მლრდ.
3,43 მლრდ.
3,55 მლრდ.
Cost of revenue
3,64 მლრდ.
3,68 მლრდ.
3,43 მლრდ.
3,55 მლრდ.
Research and development expenses
37,75 მლნ.
38,63 მლნ.
38,31 მლნ.
39,63 მლნ.
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
705,44 მლნ.
784,62 მლნ.
748,94 მლნ.
736,01 მლნ.
Operating expense
740,50 მლნ.
796,34 მლნ.
803,94 მლნ.
786,35 მლნ.
Total operating expenses
4,38 მლრდ.
4,48 მლრდ.
4,24 მლრდ.
4,34 მლრდ.
Operating income
501,72 მლნ.
592,03 მლნ.
375,56 მლნ.
523,63 მლნ.
Other non operating income
-
-
-
-
EBT including unusual items
402,57 მლნ.
508,46 მლნ.
207,52 მლნ.
383,00 მლნ.
EBT excluding unusual items
462,70 მლნ.
541,79 მლნ.
334,44 მლნ.
399,22 მლნ.
Income tax expense
75,22 მლნ.
106,44 მლნ.
42,75 მლნ.
89,83 მლნ.
Effective tax rate
18,69%
20,93%
20,60%
23,45%
Other operating expenses
-2,69 მლნ.
-26,91 მლნ.
16,69 მლნ.
10,71 მლნ.
Net income
274,80 მლნ.
327,08 მლნ.
117,53 მლნ.
218,38 მლნ.
Net profit margin
5,63%
6,45%
2,55%
4,49%
Earnings per share
1,10
1,44
0,91
0,56
Interest and investment income
19,16 მლნ.
13,62 მლნ.
14,62 მლნ.
14,70 მლნ.
Interest expense
-93,10 მლნ.
-99,02 მლნ.
-93,30 მლნ.
-97,55 მლნ.
Net interest expenses
-73,94 მლნ.
-85,40 მლნ.
-78,68 მლნ.
-82,86 მლნ.
Depreciation and amortization charges
-
-
-
-
EBITDA
853,56 მლნ.
780,17 მლნ.
727,79 მლნ.
879,38 მლნ.
Gain or loss from assets sale
50,35 მლნ.
17,92 მლნ.
8,77 მლნ.
-4,09 მლნ.
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google აპები